About Associate Professor Sarah Zaman

I am passionate about improving prevention and treatment of heart disease in women. Until recently, women’s heart disease has been under-researched and under-recognised. However, the past few years has seen it emerge as a priority research area for funding and governmental policy and now researchers in this area have the chance to make a large impact through their work.

A/Prof Zaman has several research areas – she leads a research program into Women’s Heart Disease, including prevention, awareness and a focus on reducing sex discrepancies. This involves cardiovascular disease such as coronary artery disease and myocardial infarction, as well as female-predominant conditions such as spontaneous coronary artery dissection (SCAD). She also has a thesis into prevention of sudden cardiac death – with a focus on prevention of sudden death after heart attacks. In addition, she has a research interest in diet and cardiovascular disease, and dietary interventions for primary prevention.

A/Prof Sarah Zaman is an Academic Interventional Cardiologist, who is building a nationally leading and internationally recognized Women's Heart Disease Research Program at the Westmead Applied Research Centre, University of Sydney. 
She is also a clinical Cardiologist and an Interventional Cardiologist at Westmead Hospital. She is a National Heart Foundation Future Leader Fellow and had received a NSW Health Elite post-doctoral research grant to relocate from Monash University in Melbourne back to Sydney University. She has held multiple research fellowships including a Heart Foundation Early Career Fellow, previous Monash University Early Career Practitioner Fellow & Robertson Family Cardiologist Scholar. 
A/Prof Zaman has been selected as 1 of 12 early career cardiologists globally and the first Australian to the Society for Cardiovascular Angiography & Interventions International Emerging Leader Mentorship Program. 
A/Prof Zaman has ~60 publications including multiple first/senior author papers in the top 1% of Cardiovascular Journals. 
She has received ~$2 million in competitive research funding as CIA, including from the National Heart Foundation & MRFF and more than $10 million in industry support for investigator-initiated/led trials from Abbott, Biotronik and Medtronic. She is a regularly invited national and international speaker including to the Cardiac Society of Australia/New Zealand (CSANZ), Australia/New Zealand Endovascular Therapies (ANZET), American Heart Association & Asia Pacific Cardiac Society. 
She served on the Heart Foundation Vanguard Grant Review Committee & Health Practitioner Scholarship Review Committee. She is Lead Editor for Heart, Lung & Circulation's Special Edition on Women's Heart Disease. 
A/Prof Zaman currently supervises 2 PhD candidates, 1 masters and 1 honours candidate, and mentors >10 clinician-researchers. 
Dr Zaman sits on the Australia/New Zealand Interventional Council, the ANZET Scientific Meeting Organizing Committee, is Co-Director for the Essential Percutaneous Intervention Course, convened the Women in Cardiology Symposia for CSANZ and is heavily involved in advocacy for women's heart disease.